- Erratum: Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
-
Lei C, Yang C, Xia B, Ji F, Zhang Y, Gao H, Xiong Q, Lin Y, Zhuang X, Zhang L, Zhu T, Cheng M, Yang M, Wang K
- KMID: 2500159
- J Breast Cancer.
- 2020 Apr;23(2):230-231.
- doi: 10.4048/jbc.2020.23.e19
This corrects the article “Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer” in volume 23 on page 47. This... -
- CITED
-
- Close
- SHARE
-
- Close
- A Novel Approach in Spinal Cord Stimulation for Enhancing Gastric Motility: A Preliminary Study on Canines
-
Tu L, Gharibani , Yang Y, Zhang B, Ji F, Yin J, Chen JDZ
- KMID: 2500659
- J Neurogastroenterol Motil.
- 2020 Jan;26(1):147-159.
- doi: 10.5056/jnm19101
Background/Aims Gastroparesis is commonly seen in patients with diabetes and functional dyspepsia with no satisfactory therapies. Dysautonomia is one of the main reasons for the imbalanced motility. We hypothesized that... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
-
Lei C, Yang C, Xia B, Ji F, Zhang Y, Gao H, Xiong Q, Lin Y, Zhuang X, Zhang L, Zhu T, Cheng M, Yang M, Wang K
- KMID: 2470881
- J Breast Cancer.
- 2020 Feb;23(1):47-58.
- doi: 10.4048/jbc.2020.23.e11
PURPOSE: Tau is a microtubule-associated protein that can be found in both normal and abnormal breast cells. Whether the expression of Tau protein can predict the response to neoadjuvant chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
-
Le MH, Le DM, Baez TC, Dang H, Nguyen VH, Lee K, Stave CD, Ito T, Wu Y, Yeo YH, Ji F, Cheung R, Nguyen MH
- KMID: 2554429
- Clin Mol Hepatol.
- 2024 Apr;30(2):235-246.
- doi: 10.3350/cmh.2023.0485
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with a multitude of adverse outcomes. We aimed to estimate the pooled incidence of NAFLD-related adverse events. Methods: We performed a systematic review... -
- CITED
-
- Close
- SHARE
-
- Close
